What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?

What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?

What patients with T2D are most likely to benefit from fixed-ratio combinations such a iDegLira and iGlarLixi?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jaime Davidson, MD, FACP, MACE

Jaime Davidson, MD, FACP, MACE

Clinical Professor of Medicine
Division of Endocrinology, Diabetes and Metabolism
University of Texas Southwestern Medical School
Dallas, TX